Read More 2 minute read Uncategorized Stealth Bio Stock Almost Doubles After Positive Elamipretide Data In Eye Disease Study By Vandana Singh Today, 10:05 PM Stealth BioTherapeutics Corp (NASDAQ: MITO) shares soared in the premarket session in reaction to new data from a post hoc analysis of… MITO